Everpure Breaks Out as Analysts Race to Catch Up

Options positioning has turned notably more defensive at exactly the moment the stock broke to new highs. The put/call ratio jumped to 0.81 on Wednesday, more than two standard deviations above its 20-day average of 0.76 and near the 52-week peak of 0.83 from late August. That is an unusual level of downside hedging for a stock moving this fast to the upside, suggesting some holders are buying protection into the run rather than adding long exposure. Short interest tells a different and calmer story. Bearish positioning is modest at 2.2% of free float, up about 7% on the week but down 16% over the past month. The borrow market is wide open: availability is deeply in surplus at 4,580%, meaning there are roughly 45 shares available to lend for every one currently borrowed. Cost to borrow is negligible at 0.37%. The lending setup offers no resistance to new shorts if sentiment turns, but equally no sign that bears are pressing this move.

Insider flow is worth watching carefully. The 90-day net position shows insiders selling roughly $101.7 million worth of stock, a material outflow by any measure. Most of it comes from Chief Visionary Officer John Colgrove, who sold approximately $12.5 million across multiple tranches on September 25, all conducted under a pre-arranged 10b5-1 plan. Planned sales are a weaker signal than discretionary ones; Colgrove's sales were scheduled in advance, not a reaction to current price levels. Chief Product Officer Ajay Singh was more notable: he sold $5.3 million on September 24 with no 10b5-1 plan attached, a discretionary sale on the day the stock was trading around $124. The stock has since moved roughly 23% higher. Colgrove remains a substantial holder with around 10.8 million shares. Separately, the company's remaining buyback authorisation reached a record high in Q2, up 62% year-on-year to $244.9 million, the largest Q2 buyback runway since at least 2020 according to ORTEX Alt Data drawn from SEC EDGAR XBRL filings.

The institutional register has seen meaningful recent activity. BlackRock added 4.4 million shares in the period to September 30, lifting its stake to 10.4% of shares. State Street added 4.1 million shares in the same window, taking its position to 3.5%. FMR (Fidelity) remains the largest holder at nearly 15%, though its most recent disclosure is from July. No Schedule 13D activist filings are on the register. The 13D/G disclosures are passive, with BlackRock and both Vanguard entities holding as index and long-only accounts. Retail attention has also spiked: ORTEX's Wikipedia-based attention signal registered a z-score of 3.6 as of late September, meaning the stock was drawing unusually high traffic relative to its own 90-day baseline.

The factor picture reinforces the momentum angle. EPS momentum scores in the 95th percentile over 30 days and 88th percentile over 90 days, with forward earnings estimates rising sharply. The short score sits at 31, consistent with low bearish conviction. Valuation, however, is stretched: the trailing P/E is roughly 39x and price-to-book is near 19.7x, both expanding materially over the past month. The EV/EBIT factor scores in just the 2nd percentile, confirming the stock is priced for execution on that ambitious FY28 outlook. Among peers, NTAP and HPE both rose around 12% to 13% on the week, suggesting some sector tailwind behind the move. STX fell 12% over the same period, a reminder that not all hardware names are participating equally.

The next scheduled earnings event is November 18. With the stock running 53% in a month and the analyst consensus target sitting below the current price, whether targets get revised higher into that print is the cleaner thing to watch than the short side.